Nagel, Jessica
Törmäkangas, Olli
Kuokkanen, Katja
El-Tayeb, Ali
Messinger, Josef
Abdelrahman, Aliaa
Bous, Christiane
Schiedel, Anke C.
Müller, Christa E. http://orcid.org/0000-0002-0013-6624
Funding for this research was provided by:
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 24 January 2024
Accepted: 26 March 2024
First Online: 25 May 2024
Change Date: 19 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11302-024-10030-1
Declarations
:
: Not applicable.
: The authors filed a patent on the new class of P2X4 receptor antagonists including the radioligand described in this study.